ZYBERNO
Stock Report
Updated Sep 1, 2026

Pulsenmore Ltd. (PLSM)

Healthcare • NASDAQ

$2.62

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
19.0/100
POOR BUSINESS
Pulsenmore Ltd. (PLSM) scores 19/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (0.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Pulsenmore Ltd. (PLSM) stock report — Zyberno Score 19/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.62
Market Cap:$17.04M

Valuation Multiples (3)

P/B Ratio:0.65x
P/S Ratio:1.36x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$10.26M
B. Profitability Assessment

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:7.88x
Quick Ratio:5.95x
Cash Ratio:2.09x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:0.00x
Times Interest Earned:0.00

Capital Structure (4)

Working Capital:22,281,000.00
Cash And Cash Equivalents:6,773,000.00
Long Term Debt:$0.00
Net Debt:-$6.77M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$12.55M
Cost Of Revenue Ttm:$1.99M

Profitability Breakdown (2)

$10.56M$0.00

Bottom Line Performance (3)

-$4.97M
Income Before Tax:$0.00
Ebitda Ttm:0.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:0.00
Sga Expense:0.00
Income Tax Expense:$333.24
Interest Expense:2,265,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:0.0%
Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$31.93M
Current Assets:$25.52M
Ppe Net:1,825,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:5,881,000.00
Current Liabilities:3,239,000.00
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$26.05M
Retained Earnings:$0.00
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:6,248,000.00
Accounts Payable:621,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$10.31M-$10.35M

Investment Activities (1)

Investing Cash Flow:$4.34M

Financing Activities (3)

Financing Cash Flow:$2.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$0.76

Revenue & Cash Per Share (2)

Sales Per Share Ttm:1.93
Operating Cash Flow Per Share:-$1.58

Book Value & Capital (2)

Book Value Per Share:$4.01
Cash Per Share:1.04

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.39x
Working Capital Turnover Ttm:0.56x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:0.32x
Days Inventory Outstanding Ttm:1,147.14

Payables & Cash Cycle (2)

Days Payable Outstanding:114.02
Cash Conversion Cycle:34.13
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:PLSM
Company Name:Pulsenmore Ltd.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:6.50M
Shares Outstanding Basic:0
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 09:48:34 UTC
Data Timestamp:2026-08-21T00:13:46.085905
Scroll to Top